Quick Takeaways
- Avidity Partners Management LP filed SCHEDULE 13D/A for Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH).
- Disclosed ownership: 9.9%.
- Date of event: 17 Mar 2025.
Quoteable Key Fact
"Avidity Partners Management LP disclosed 9.9% ownership in Dianthus Therapeutics, Inc. /DE/ Common Stock, $0.001 par value (DNTH) on 17 Mar 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Avidity Partners Management LP | 9.9% | 3,378,939 | 0 | 3,378,939 | By Avidity Partners Management (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | 0001791827 |
| Avidity Partners Management (GP) LLC | 9.9% | 3,378,939 | 0 | 3,378,939 | By: /s/ Michael Gregory | Michael Gregory / Managing Member | 0001993910 |
| Avidity Capital Partners Fund (GP) LP | 9.9% | 3,378,939 | 0 | 3,378,939 | By Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Avidity Capital Partners (GP) LLC | 9.9% | 3,378,939 | 0 | 3,378,939 | By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Avidity Master Fund LP | 2.3% | 764,610 | 0 | 764,610 | By Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Avidity Private Master Fund I LP | 8.3% | 2,749,625 | 0 | 2,749,625 | By Avidity Capital Partners Fund (GP) LP, its general partner, By: Avidity Capital Partners (GP) LLC, its general partner, By: /s/ Michael Gregory | Michael Gregory / Managing Member | |
| Michael Gregory | 9.9% | 3,378,939 | 0 | 3,378,939 | By: /s/ Michael Gregory | Michael Gregory | 0001993963 |